Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: Implications for the treatment of autoimmunity

Journal of Autoimmunity

Volumn 39, Issue 3, 2012, Pages 180-188

  Mumtaz, Imtiaz M ^a,b   Hoyer, Bimba F ^a,b   Panne, Daniel ^a,b   Moser, Katrin ^b   Winter, Oliver ^b   Cheng, Qingyu Y ^a,b   Yoshida, Taketoshi ^a,b   Burmester, Gerd R ^a,b,c   Radbruch, Andreas ^b   Manz, Rudolf A ^b,c   Hiepe, Falk ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b POTSDAM INSTITUTE FOR CLIMATE IMPACT RESEARCH PIK   (Germany)

^c The Institute for Systemic Inflammation Research (ISEF)   (Germany)

Author keywords

Autoantibodies; Long lived memory plasma cells; Lupus nephritis; NZB W F1 mice

Indexed keywords

BROXURIDINE; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DEXAMETHASONE; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BONE MARROW; CONTROLLED STUDY; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOID ORGAN; MEMORY CELL; MOUSE; NEPHRITIS; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SPLEEN;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; BONE MARROW; BROMODEOXYURIDINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DNA; FEMALE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LUPUS NEPHRITIS; MICE; MICE, INBRED NZB; ORGAN SPECIFICITY; PLASMA CELLS; SPLEEN;

EID: 84865375469     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.05.010     Document Type: Article

References (58)

1. Radbruch A., Muehlinghaus G., Luger E.O., Inamine A., Smith K.G., Dorner T., et al. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 2006, 6:741-750.
2. Hiepe F., Dörner T., Hauser A.E., Hoyer B.F., Mei H., Radbruch A. Long-lived autoreactive plasma cells drive persistent autoimmune inflammation. Nat Rev Rheumatol 2011, 7:170-178.
3. Hoyer B.F., Moser K., Hauser A.E., Peddinghaus A., Voigt C., Eilat D., et al. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J Exp Med 2004, 199:1577-1584.
4. Alexander T., Thiel A., Rosen O., Massenkeil G., Sattler A., Kohler S., et al. Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system. Blood 2009, 113:214-223.
5. Neubert K., Meister S., Moser K., Weisel F., Maseda D., Amann K., et al. The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat Med 2008, 14:748-755.
6. Cassese G., Lindenau S., de Boer B., Arce S., Hauser A., Riemekasten G., et al. Inflamed kidneys of NZB/W mice are a major site for the homeostasis of plasma cells. Eur J Immunol 2001, 31:2726-2732.
7. Espeli M., Bokers S., Giannico G., Dickinson H.A., Bardsley V., Fogo A.B., et al. Local renal autoantibody production in lupus nephritis. J Am Soc Nephrol 2011, 22:296-305.
8. Schroder A.E., Greiner A., Seyfert C., Berek C. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci U S A 1996, 93:221-225.
9. Szyszko E.A., Brokstad K.A., Oijordsbakken G., Jonsson M.V., Jonsson R., Skarstein K. Salivary glands of primary Sjogren's syndrome patients express factors vital for plasma cell survival. Arthritis Res Ther 2011, 13:R2.
10. Fleischmajer R., Perlish J.S., Reeves J.R. Cellular infiltrates in scleroderma skin. Arthritis Rheum 1977, 20:975-984.
11. Manz R.A., Lohning M., Cassese G., Thiel A., Radbruch A. Survival of long-lived plasma cells is independent of antigen. Int Immunol 1998, 10:1703-1711.
12. Hauser A.E., Debes G.F., Arce S., Cassese G., Hamann A., Radbruch A., et al. Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response. J Immunol 2002, 169:1277-1282.
13. Kunkel E.J., Butcher E.C. Plasma-cell homing. Nat Rev Immunol 2003, 3:822-829.
14. Hofer T., Muehlinghaus G., Moser K., Yoshida T., Hebel K., et al. Adaptation of humoral memory. Immunol Rev 2006, 211:295-302.
15. Benner R., Hijmans W., Haaijman J.J. The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation. Clin Exp Immunol 1981, 46:1-8.
16. Amanna I.J., Carlson N.E., Slifka M.K. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007, 357:1903-1915.
17. Ferraro A.J., Drayson M.T., Savage C.O., MacLennan I.C. Levels of autoantibodies, unlike antibodies to all extrinsic antigen groups, fall following B cell depletion with rituximab. Eur J Immunol 2008, 38:292-298.
18. Muehlinghaus G., Cigliano L., Huehn S., Peddinghaus A., Leyendeckers H., Hauser A.E., et al. Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells. Blood 2005, 105:3965-3971.
19. Chervenick P.A., Boggs D.R., Marsh J.C., Cartwright G.E., Wintrobe M.M. Quantitative studies of blood and bone marrow neutrophils in normal mice. Am J Physiol 1968, 215:353-360.
20. Manz R.A., Thiel A., Radbruch A. Lifetime of plasma cells in the bone marrow. Nature 1997, 388:133-134.
21. Slifka M.K., Ahmed R. Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr Opin Immunol 1998, 10:252-258.
22. Fauci A.S. Mechanisms of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and b lymphocytes to the bone marrow. Immunology 1975, 28:669-680.
23. Levine M.A., Claman H.N. Bone marrow and spleen: dissociation of immunologic properties by cortisone. Science 1970, 167:1515-1517.
24. Maruyama S., Minagawa M., Shimizu T., Oya H., Yamamoto S., Musha N., et al. Administration of glucocorticoids markedly increases the numbers of granulocytes and extrathymic T cells in the bone marrow. Cell Immunol 1999, 194:28-35.
25. Starke C., Frey S., Wellmann U., Urbonaviciute V., Herrmann M., Amann K., et al. High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice. Eur J Immunol 2011, 41:2107-2112.
26. Crook T.R., Souhami R.L., McLean A.E. Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells. Cancer Res 1986, 46:5029-5034.
27. Buttgereit F., Wehling M., Burmester G.R. A new hypothesis of modular glucocorticoid actions: steroid treatment of rheumatic diseases revisited. Arthritis Rheum 1998, 41:761-767.
28. Chauhan D., Pandey P., Ogata A., Teoh G., Treon S., Urashima M., et al. Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism. Oncogene 1997, 15:837-843.
29. Yaccoby S. The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype. Clin Cancer Res 2005, 11:7599-7606.
30. Barnes P.J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997, 336:1066-1071.
31. Li Z.W., Dalton W.S. Tumor microenvironment and drug resistance in hematologic malignancies. Blood Rev 2006, 20:333-342.
32. Tokoyoda K., Egawa T., Sugiyama T., Choi B.I., Nagasawa T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 2004, 20:707-718.
33. Tokoyoda K., Hauser A.E., Nakayama T., Radbruch A. Organization of immunological memory by bone marrow stroma. Nat Rev Immunol 2010, 10:193-200.
34. O'Connor B.P., Raman V.S., Erickson L.D., Cook W.J., Weaver L.K., Ahonen C., et al. BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med 2004, 199:91-98.
35. Moreaux J., Legouffe E., Jourdan E., Quittet P., Reme T., Lugagne C., et al. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 2004, 103:3148-3157.
36. Gross J.A., Johnston J., Mudri S., Enselman R., Dillon S.R., Madden K., et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 2000, 404:995-999.
37. Yoshida T., Mei H., Dorner T., Hiepe F., Radbruch A., Fillatreau S., et al. Memory B and memory plasma cells. Immunol Rev 2010, 237:117-139.
38. Benner R., van Dongen J.J., van Oudenaren A. Corticosteroids and the humoral immune response of mice i. Differential effect of corticosteroids upon antibody formation to sheep red blood cells in spleen and bone marrow. Cell Immunol 1978, 41:52-61.
39. Sabbele N.R., van Oudenaren A., Benner R. The effect of corticosteroids upon the number and organ distribution of "background" immunoglobulin-secreting cells in mice. Cell Immunol 1983, 77:308-317.
40. Papoian R., Pillarisetty R., Talal N. Immunological regulation of spontaneous antibodies to DNA and RNA. II. Sequential switch from IgM to IgG in NZB/NZW F1 mice. Immunology 1977, 32:75-79.
41. Steward M.W., Hay F.C. Changes in immunoglobulin class and subclass of anti-DNA antibodies with increasing age in N/ZBW F1 hybrid mice. Clin Exp Immunol 1976, 26:363-370.
42. Holmes M.C., Burnet F.M. The natural history of autoimmune disease in Nzb mice. A comparison with the pattern of human autoimmune manifestations. Ann Intern Med 1963, 59:265-276.
43. Rosen O., Thiel A., Massenkeil G., Hiepe F., Haupl T., Radtke H., et al. Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells. Arthritis Res 2000, 2:327-336.
44. Alexander T., Thiel A., Rosen O., Massenkeil G., Sattler A., Kohler S., et al. Depletion of autoreactive immunological memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system. Blood 2008.
45. Balabanian K., Couderc J., Bouchet-Delbos L., Amara A., Berrebi D., Foussat A., et al. Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus. J Immunol 2003, 170:3392-3400.
46. Chu V.T., Enghard P., Schurer S., Steinhauser G., Rudolph B., Riemekasten G., et al. Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus. Arthritis Rheum 2009, 60:2083-2093.
47. Hiepe F., Hoyer B., Alexander T., Taddeo A., Voll R., Radbruch A. Therapeutic inhibition of proteasomes in systemic lupus erythematosus. J Translational Med 2011, 9:I9.
48. Hiepe F., Alexander T., Peukert R., Rubbert A., Rech J., Braun T., et al. Refractory SLE patients respond to the proteasome inhibitor bortezomib. Ann Rheum Dis 2012, 71:A15-A16.
49. Zand M.S., Vo T., Huggins J., Felgar R., Liesveld J., Pellegrin T., et al. Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways. Transplantation 2005, 79:1507-1515.
50. Rose N.R. The genetics of autoimmune thyroiditis: the first decade. J Autoimmun 2011, 37:88-94.
51. Kapsogeorgou E.K., Gourzi V.C., Manoussakis M.M., Moutsopoulos H.M., Tzioufas A.G. Cellular microRNAs (miRNAs) and Sjogren's syndrome: candidate regulators of autoimmune response and autoantigen expression. J Autoimmun 2011, 37:129-135.
52. Gershwin M.E., Shoenfeld Y. Chella David: a lifetime contribution in translational immunology. J Autoimmun 2011, 37:59-62.
53. Behrens M., Smart M., Luckey D., Luthra H., Taneja V. To B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice. J Autoimmun 2011, 37:95-103.
54. Mackay I.R., Leskovsek N.V., Rose N.R. The odd couple: a fresh look at autoimmunity and immunodeficiency. J Autoimmun 2010, 35:199-205.
55. Youinou P. Haralampos M. Moutsopoulos: a lifetime in autoimmunity. J Autoimmun 2010, 35:171-175.
56. Miyagawa F., Gutermuth J., Zhang H., Katz S.I. The use of mouse models to better understand mechanisms of autoimmunity and tolerance. J Autoimmun 2010, 35:192-198.
57. Mavragani C.P., Crow M.K. Activation of the type I interferon pathway in primary Sjogren's syndrome. J Autoimmun 2010, 35:225-231.
58. Juran B.D., Lazaridis K.N. Update on the genetics and genomics of PBC. J Autoimmun 2010, 35:181-187.